HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via Google Scholar Google Scholar Articles by JUDELSOHN, R. G. Articles by BRANCH, B. N. Search for Related Content PubMed PubMed Citation Articles by JUDELSOHN, R. G. Articles by BRANCH, B. N.

Optimal Utilization of Rh Immunoglobulin in Induced Abortion

From the Department of Health, Education and Welfare, Public Health Service, Center for Disease Control, Atlanta, Georgia.

In an effort to design a procedure for optimal utilization of Rh immunoglobulin in induced abortion, methods for 1) rapid identification of Rh-negative women, 2) transmission of information on Rh type and globulin to such women, and 3) transfer of Rh immunoglobulin to the medical area were established in a high-volume outpatient abortion service. During a 7-week period, 255 of 265 Rh-negative unimmunized women received Rh immunoglobulin. Nine of the 10 women refusing it were older multiparas. Previous surveys show utilization rates ranging from 42 to 68%; the present study demonstrates that optimal utilization can be approached with the appropriate procedures. With increasing incidence of induced abortion, such procedures are vital if Rh immunization and Rh hemolytic disease of the newborn are to be prevented.